If you’ve walked into a gym, CrossFit box, MMA academy chances are you’ve heard whispers about BPC-157 – the peptide that supposedly heals tendons, ligaments, and muscles at lightning speed. Some athletes call it the “Wolverine compound” because of its almost sci-fi regenerative reputation.
At Shannon Clinic Melbourne, we’re passionate about regenerative medicine and orthobiologics in sports and general care — closely tracking the latest evidence as it evolves. In recent months, Melbourne sports chiropractor Dr. Shannon has been asked frequently about BPC-157. We will share with you what we have told those patients, focusing on answering some of the key questions. Is it safe? Does it actually work in humans? And should you consider taking it?
We reviewed the latest evidence available, which includes: 1 systematic review, 1 narrative review, 1 general review and 1 pilot study in humans. Let’s break down the latest 2024–2025 research in plain English.
What Exactly Is BPC-157?
BPC-157 (Body Protection Compound 157) is a tiny chain of 15 amino acids originally discovered in human gastric (stomach) juice. Scientists created a stable synthetic version that, in animal studies, appears to speed up healing in muscles, tendons, ligaments, bones, and even the gut.
How Does BPC-157 Work? (Explained for Non-Scientists)
Think of your body like a construction site after an injury. Normally, repair crews (blood vessels, fibroblasts, macrophages etc) take time to arrive and fix the damage – especially in “low-traffic” areas like tendons and ligaments that don’t get much blood flow.
Preclinical (mostly rat) studies show BPC-157 acts like a supercharged project manager that:
- Builds new blood vessels super fast (angiogenesis) → It switches on the VEGF system (the same one your body uses to grow new capillaries) and boosts nitric oxide so fresh blood, oxygen, and nutrients flood the injured area.
- Calls in the repair crew early → Increases growth hormone receptors on tendon and muscle cells, ramps up collagen production, and tells fibroblasts (the cells that make scar tissue and new tissue) to get to work.
- Calms the fire (reduces inflammation without killing it completely) → Lowers destructive inflammatory chemicals (TNF-α, IL-6) while protecting your mitochondria (the power plants inside cells) from oxidative damage.
- Protects and stabilises nerves and blood vessels → Helps nerves regrow and prevents blood vessels from leaking or rupturing under stress.
In short: animals given BPC-157 heal Achilles tendons, muscle tears, ligament injuries, and even crushed bones dramatically faster and stronger than untreated animals. The results have been consistent across dozens of high-quality rat studies that researchers got very excited.
👉Interested in longevity? Resveratol and NMN are emerging supplements that could help extend life, read what Melbourne city chiropractor says the evidence is telling us.
The Big Problem: Where’s the Human Evidence?
Here’s what the four newest 2024 PubMed papers actually say about people:
- Only 3–4 tiny human studies exist worldwide (total participants < 30).
- One intra-articular (into the knee joint) case series of 12 people with chronic knee pain found 7 out of 12 had major pain relief lasting over 6 months.
- A brand-new 2024 pilot gave two healthy adults up to 20 mg intravenously for two days – zero side effects, normal blood tests, heart, liver, kidney, and thyroid markers all fine.
- No large randomised controlled trials. Zero. None.
Translation: the animal data is extremely strong, but the human data is basically anecdotal plus a couple of pilot studies.
Is BPC-157 Safe for Humans Right Now?
Short answer: We simply don’t know long-term.
- In the tiny human trials so far → it is well tolerated, but the sample sizes are small and selective (this isn’t a good representation of either a). the athletic population or b). the general population).
- No changes in cancer markers, hormones, liver, or kidney function reported (only monitored in the short term – days).
- It’s completely unregulated and does not have FDA approval – you’re buying it from overseas compounding pharmacies or “research chemical” websites with zero quality control. Contamination and dosing errors are real risks.
- Interactions with other drugs or supplements are currently unknown.
It is also banned by WADA (World Anti-Doping Agency) and ASADA, so competitive athletes can (and have) received bans for using it.
Should You Try BPC-157 in 2025?
On the weight of the current evidence, Melbourne city sports chiropractor, Dr. Shannon offers the summary below:
- The preclinical science is genuinely exciting and promising for regenerative medicine.
- Right now in 2025 there is still not enough high-quality human evidence to call it “safe and effective” by Australian medical standards.
- Anyone using BPC-157 should consider that the safety and risks are completely unknown in humans, the dose required to create a therapeutic effect is unknown, the long term implications for using BPC-157 is also unknown.
- The Shannon Clinic Melbourne is a progressive sports chiropractor practice and we pride ourselves on being at the cutting edge of regenerative medicine and orthobiologics and incorporate these into managing athletes and patients where appropriate and where the evidence guides its use, which is reflective of our current position stand on BPC-157 (see below).
Bottom Line
Research on BPC-157 as a regenerative peptides is promising in animals, but the human trial data is low quality, extremely sparse and in many cases completely absent. Other orthobiologics such as stem cells or PRP, even newly developed cell editing drugs like Invossa for knee osteoarthritis have robust safety data in humans and ongoing randomized controlled trials to determine their efficacy.
BPC-157 is currently highly experimental in humans. BPC-157 requires robust safety trials in humans first, then trials to determine the dose-response required to elicit meaningful therapeutic regenerative changes, followed by trials to establish the long term safety. Melbourne sports chiropractor, Dr. Shannon says based on the evidence BPC-157 cannot currently be recommended as a treatment option in regenerative and sports medicine for patients with tendon, muscle and ligament injuries.
If you’re dealing with chronic tendon pain, a slow-healing injury, or you’re an athlete looking for the next edge, talk to a qualified sports chiropractor in Melbourne who stays up-to-date with the evidence for regenerative and orthobiological medicine. There are other options for tendon and ligament injuries such as PRP which is safe and effective in certain injuries, these are more appropriate and when combined with rehabilitation often result in favourable outcomes.
Looking for a sports chiropractor in Melbourne CBD who understands the latest in regenerative medicine and peptide research? → Book a consultation at Shannon Clinic Melbourne. You can find our Melbourne city chiropractic clinic location here.
